# Brighthouse Financial, Inc.: financial statements, quarterly

BHF · Nasdaq · CIK 1685040 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bhf.md) · [Financials](/companies/bhf/financials.md) · [Filings](/companies/bhf/filings.md) · [Insiders](/companies/bhf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bhf/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,170](/filings/0001685040-24-000053.md) | [1,400](/filings/0001685040-24-000007.md) | [74.0](/filings/0001685040-25-000018.md) | [1,427](/filings/0001685040-25-000048.md) | [2,018](/filings/0001685040-25-000071.md) | [1,205 d](/filings/0001685040-26-000011.md) | [2,390](/filings/0001685040-26-000019.md) | [871](/filings/0001685040-26-000028.md) | [1,816](/filings/0001685040-25-000071.md) | [1,689 d](/filings/0001685040-26-000011.md) | [1,527](/filings/0001685040-26-000019.md) | [1,622](/filings/0001685040-26-000028.md) |
| Income tax | $m | [109](/filings/0001685040-24-000053.md) | [(258) d](/filings/0001685040-26-000011.md) | [(123)](/filings/0001685040-25-000018.md) | [(20.0)](/filings/0001685040-25-000048.md) | [10.0](/filings/0001685040-25-000071.md) | [162 d](/filings/0001685040-26-000011.md) | [(88.0)](/filings/0001685040-26-000019.md) | [8.0](/filings/0001685040-26-000028.md) | [104](/filings/0001685040-25-000071.md) | [12.0 d](/filings/0001685040-26-000011.md) | [(222)](/filings/0001685040-26-000019.md) | [245](/filings/0001685040-26-000028.md) |
| Net income | $m | [479](/filings/0001685040-24-000053.md) | [(917)](/filings/0001685040-24-000007.md) | [(493)](/filings/0001685040-25-000018.md) | [34.0](/filings/0001685040-25-000048.md) | [176](/filings/0001685040-25-000071.md) | [671 d](/filings/0001685040-26-000011.md) | [(268)](/filings/0001685040-26-000019.md) | [85.0](/filings/0001685040-26-000028.md) | [479](/filings/0001685040-25-000071.md) | [137 d](/filings/0001685040-26-000011.md) | [(766)](/filings/0001685040-26-000019.md) | [981](/filings/0001685040-26-000028.md) |
| Diluted EPS | $ per share | [6.89](/filings/0001685040-24-000053.md) | [(14.70)](/filings/0001685040-24-000007.md) | [(8.22)](/filings/0001685040-25-000018.md) | [0.12](/filings/0001685040-25-000048.md) | [2.47](/filings/0001685040-25-000071.md) | not reported | [(5.04)](/filings/0001685040-26-000019.md) | [1.02](/filings/0001685040-26-000028.md) | [7.89](/filings/0001685040-25-000071.md) | not reported | [(13.82)](/filings/0001685040-26-000019.md) | [16.53](/filings/0001685040-26-000028.md) |
| Basic EPS | $ per share | [6.92](/filings/0001685040-24-000053.md) | [(14.70)](/filings/0001685040-24-000007.md) | [(8.22)](/filings/0001685040-25-000018.md) | [0.12](/filings/0001685040-25-000048.md) | [2.49](/filings/0001685040-25-000071.md) | not reported | [(5.04)](/filings/0001685040-26-000019.md) | [1.03](/filings/0001685040-26-000028.md) | [7.93](/filings/0001685040-25-000071.md) | not reported | [(13.82)](/filings/0001685040-26-000019.md) | [16.62](/filings/0001685040-26-000028.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [224](/filings/0001685040-23-000073.md) | [236](/filings/0001685040-25-000010.md) | [240](/filings/0001685040-24-000019.md) | [237](/filings/0001685040-24-000037.md) | [245](/filings/0001685040-24-000053.md) | [239](/filings/0001685040-26-000011.md) | [235](/filings/0001685040-25-000018.md) | [243](/filings/0001685040-25-000048.md) | [245](/filings/0001685040-25-000071.md) | [242](/filings/0001685040-26-000028.md) | [237](/filings/0001685040-26-000019.md) | [247](/filings/0001685040-26-000028.md) |
| Total liabilities | $bn | [219](/filings/0001685040-23-000073.md) | [231](/filings/0001685040-25-000010.md) | [235](/filings/0001685040-24-000019.md) | [233](/filings/0001685040-24-000037.md) | [240](/filings/0001685040-24-000053.md) | [234](/filings/0001685040-26-000011.md) | [229](/filings/0001685040-25-000018.md) | [237](/filings/0001685040-25-000048.md) | [238](/filings/0001685040-25-000071.md) | [235](/filings/0001685040-26-000028.md) | [231](/filings/0001685040-26-000019.md) | [241](/filings/0001685040-26-000028.md) |
| Long-term debt | $bn | [3.2](/filings/0001685040-23-000073.md) | [3.2](/filings/0001685040-25-000010.md) | [3.2](/filings/0001685040-24-000019.md) | [3.2](/filings/0001685040-24-000037.md) | [3.2](/filings/0001685040-24-000053.md) | [3.2](/filings/0001685040-26-000011.md) | [3.2](/filings/0001685040-25-000018.md) | [3.2](/filings/0001685040-25-000048.md) | [3.2](/filings/0001685040-25-000071.md) | [3.2](/filings/0001685040-26-000028.md) | [3.2](/filings/0001685040-26-000019.md) | [3.2](/filings/0001685040-26-000028.md) |
| Shareholders' equity | $bn | [4.1](/filings/0001685040-23-000073.md) | [4.9](/filings/0001685040-25-000010.md) | [4.2](/filings/0001685040-24-000019.md) | [4.1](/filings/0001685040-24-000037.md) | [5.5](/filings/0001685040-24-000053.md) | [5.0](/filings/0001685040-26-000011.md) | [5.2](/filings/0001685040-25-000018.md) | [5.7](/filings/0001685040-25-000048.md) | [6.4](/filings/0001685040-25-000071.md) | [6.8](/filings/0001685040-26-000028.md) | [5.6](/filings/0001685040-26-000019.md) | [6.6](/filings/0001685040-26-000028.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [339 d](/filings/0001685040-24-000053.md) | [152 d](/filings/0001685040-26-000011.md) | [(530)](/filings/0001685040-25-000018.md) | [334 d](/filings/0001685040-25-000048.md) | [24.0 d](/filings/0001685040-25-000071.md) | [(118) d](/filings/0001685040-26-000011.md) | [146](/filings/0001685040-26-000019.md) | [(1.0) d](/filings/0001685040-26-000028.md) | [117 d](/filings/0001685040-25-000071.md) | [(3.0) d](/filings/0001685040-26-000011.md) | [(221)](/filings/0001685040-26-000019.md) | [(431) d](/filings/0001685040-26-000028.md) |
| Share repurchases | $m | [64.0 d](/filings/0001685040-24-000053.md) | [60.0 d](/filings/0001685040-26-000011.md) | [62.0](/filings/0001685040-25-000018.md) | [64.0 d](/filings/0001685040-25-000048.md) | [64.0 d](/filings/0001685040-25-000071.md) | [60.0 d](/filings/0001685040-26-000011.md) | [59.0](/filings/0001685040-26-000019.md) | [43.0 d](/filings/0001685040-26-000028.md) | [0.0 d](/filings/0001685040-25-000071.md) | [0.0 d](/filings/0001685040-26-000011.md) | [0.0](/filings/0001685040-26-000019.md) | [0.0 d](/filings/0001685040-26-000028.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [72.0](/filings/0001685040-23-000073.md) | [67.9](/filings/0001685040-24-000019.md) | [66.7](/filings/0001685040-24-000037.md) | [65.7](/filings/0001685040-24-000053.md) | [63.0](/filings/0001685040-25-000018.md) | [62.3](/filings/0001685040-25-000048.md) | [60.9](/filings/0001685040-25-000071.md) | [58.3](/filings/0001685040-26-000019.md) | [57.7](/filings/0001685040-26-000028.md) | [57.5](/filings/0001685040-25-000071.md) | [57.3](/filings/0001685040-26-000019.md) | [57.8](/filings/0001685040-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 57,511,563 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001685040-26-000028.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.